Eligibility criteria to cisplatin in head and neck squamous cell carcinoma: Egyptian expert opinion

INTRODUCTION: The use of cisplatin in clinical practice in the management of head and neck squamous cell carcinoma (HNSCC) is limited by its toxicity and acquired resistance, which makes the decision‐making process of its prescription multifactorial. METHODS: An Egyptian expert panel (comprising nin...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulla, Mohamed, Belal, Abdel Aziz, Sakr, Amr, El Arab, Lobna E., Mokhtar, Mohsen, Allahloubi, Nasr, Ghali, Ramy, Hashem, Tarek, Arafat, Waleed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Guidance Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847398/
https://www.ncbi.nlm.nih.gov/pubmed/36698712
http://dx.doi.org/10.1002/hsr2.1037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9847398/
https://www.ncbi.nlm.nih.gov/pubmed/36698712
http://dx.doi.org/10.1002/hsr2.1037

Ejemplares similares